Mental Health

Emotional Link LLC CEO Naoto Sato Interviews Associate Professor Mai Uchida, Harvard Medical School, on "How to deal with Blowing up on SNS"

TOKYO, Sept. 27, 2023 /PRNewswire/ -- Emotional Link LLC , a business information dissemination company based inChuo Ward, Tokyo, has released an interview article with Associate ProfessorMai Uchida, Harvard Medical School, on "How to deal with Blowing up on SNS". ...

2023-09-27 22:00 3312

Growing Awareness of Brain Health for Senior Dogs as Cascade Animal Sciences Launches "Neuro-Pro"

ATLANTA, June 20, 2023 /PRNewswire/ -- Cascade Animal Sciences, an animal health start-up based inthe United States and Australia, is proud to announce the launch of its first dietary supplement product "Neuro-Pro".  Neuro-Pro is designed for middle-to-senior-aged dogs and dogs that require neuro...

2023-06-20 22:17 2922

MINDLAX REVOLUTIONIZES SLEEP SOLUTIONS WITH VIBROACOUSTIC SLEEPING MAT

The MindLax Sleeping Mat uses tactile-aural mechanisms that trigger the body's natural processes to induce relaxation and aid better sleep COLORADO SPRINGS, Colo., Feb. 20, 2023 /PRNewswire/ -- MindLax, the leading innovator in natural sleep and relaxation products and maker of the MindLax Sleep...

2023-02-21 00:00 2991

Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial

Approximately 5% of Americans suffer from Major Depressive Disorder (MDD),[1]  which is commonly associated with "foggy thinking" but a new clinical trial raises hope that once-a-day oral drug Xanamem® may assist where treatment by anti-depressant medication alone is inadequate SYDNEY, Dec. 14, 2...

2022-12-14 21:52 2650

University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health

- World's First Research into Relationship between Rich-in-Biodiversity Garden Greenery and Health/Well-being - TOKYO, Dec. 6, 2022 /PRNewswire/ -- The University of Tokyo's Graduate School of Agricultural and Life Sciences (GSALS) and Sekisui House, Ltd. launched a joint research project on bio...

2022-12-06 14:00 2224

Ybrain Receives Translational Research Award 2022 Neuroergonomics Conference & NYC Neuromodulation Conference

NEW YORK, Aug. 18, 2022 /PRNewswire/ -- Ybrain recently received the Translational Research Award at this year'sNeuroergonomics Conference and NYC Neuromodulation Conference held fromJuly 28 to August 1 for its neuromodulation technology in tran...

2022-08-18 20:00 2461

Announcing the Release of The Disruptors, the First Comprehensive Documentary Film on ADHD Award-Winning, Star-Studded Documentary Available in Australia on Apple TV/iTunes, Google Play, and YouTube

GREENWICH, Conn., Aug. 17, 2022 /PRNewswire/ -- Following its successful US debut, THE DISRUPTORS – the first definitive, comprehensive documentary film on ADHD, one of the most commonly diagnosed, and widely misunderstood neurological conditions in the world today – is now available inAustralia ...

2022-08-18 05:23 6581

Taiwanese Startup E-Kids Helps the Elderly with Butler Services Built on Psychotherapy Principles

* Butler-type service provides companionship and services such as tech assistance * Elderly are served by youths trained to communicate using psychotherapy principles * Psychotherapy matters a lot to many people all over the world, E-Kids to help deliver TAIPEI, July 28, 2022 /PRNewswire/ -...

2022-07-29 10:37 2454

THE WORLD'S FIRST ACADEMIC PAPER ON THE POTENTIAL USE OF VIRTUAL REALITY IN MODULATING PSYCHEDELIC-ASSISTED PSYCHOTHERAPY PUBLISHED BY THE CO-FOUNDERS OF ENOSIS THERAPEUTICS

The Peer-Reviewed Article Published In Volume 13 March 2022 Issue Of Frontiers In Psychology Journal Is A Landmark Examination Of Virtual Reality Therapy Combined With Psychedelic Therapy.  MELBOURNE, Australia, March 10, 2022 /PRNewswire/ -- The world's first scientific paper offering a careful...

2022-03-10 21:00 2166

Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease

MELBOURNE, Australia, Jan. 28, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that data in an animal model of Multiple S...

2022-01-28 20:08 2780

U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute Treatment of Social Anxiety Disorder and Other Anxiety Related Disorders

ADELAIDE, Australia, Dec. 1, 2021 /PRNewswire/ -- Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the BNC210 development progr...

2021-12-01 19:00 3248

Paw for Good launches crowdfunding program to create a mutually beneficial ecosystem by transforming stray dogs into instructors for people with special needs

TAOYUAN, Taiwan, Sept. 9, 2021 /PRNewswire/ -- In September 2021, the Paw for Good team of Chung Yuan University Industry Accelerator and Incubator Center (IAIC) launched thePaw For Good Interactive Education Program in coope...

2021-09-10 13:37 2316

LG SIGNATURE Concludes Charity Auction Benefiting Families Affected by Autism

SEOUL, South Korea, July 22, 2021 /PRNewswire/ -- LG Electronics (LG) has pledged all proceeds from itsSTRONGER TOGETHER charity auction (July 8-18) to Sur les bancs de l'école, a French non-profit organization that has been supporting young people with Autism Spectrum Disorders (ASD) since 2008....

2021-07-23 09:00 8995

RBC Expands Global Youth Charity Program - RBC Charity Day for the Kids

* Virtual celebrations held by RBC Capital Markets employees in Canada, U.S., U.K.,France, Germany, Japan, Hong Kong, Australia, Barbados and Bahamas * US$5 million donated to over 50 charities worldwide SYDNEY, June 18, 2021 /PRNewswire/ -- As part of a global charitable initiative called RBC...

2021-06-17 20:00 2459
12

Week's Top Stories